Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Other Non-Current Liabilities (2020 - 2025)

Historic Other Non-Current Liabilities for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to $8.1 million.

  • Legend Biotech's Other Non-Current Liabilities rose 2999259.26% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 2999259.26%. This contributed to the annual value of $6.2 million for FY2024, which is 1088928.57% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Other Non-Current Liabilities is $8.1 million, which was up 2999259.26% from $6.2 million recorded in Q4 2024.
  • In the past 5 years, Legend Biotech's Other Non-Current Liabilities registered a high of $8.1 million during Q3 2025, and its lowest value of $554.0 during Q1 2021.
  • Over the past 5 years, Legend Biotech's median Other Non-Current Liabilities value was $188000.0 (recorded in 2023), while the average stood at $1.2 million.
  • Per our database at Business Quant, Legend Biotech's Other Non-Current Liabilities surged by 6415992.78% in 2022 and then plummeted by 8660.71% in 2024.
  • Quarter analysis of 5 years shows Legend Biotech's Other Non-Current Liabilities stood at $396000.0 in 2021, then crashed by 41.16% to $233000.0 in 2022, then crashed by 75.97% to $56000.0 in 2023, then soared by 10889.29% to $6.2 million in 2024, then soared by 32.03% to $8.1 million in 2025.
  • Its Other Non-Current Liabilities was $8.1 million in Q3 2025, compared to $6.2 million in Q4 2024 and $27000.0 in Q3 2024.